Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
BMC Immunology|November 26, 2009
Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathwayOlga V Efimova, Todd W KelleyFrontiers in Bioscience (Scholar Edition)|June 3, 2010
CD4 (+)CD25 (+)Foxp3 (+) regulatory T cells and hematologic malignanciesTodd W Kelley, Charles J ParkerMethods in Molecular Biology (Clifton, N.J.)|July 24, 2017
Detection and Quantification of Acute Myeloid Leukemia-Associated Fusion TranscriptsJonathan Schumacher, Philippe Szankasi, Todd W KelleyPlos One|January 22, 2011
Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cellsOlga Efimova, Philippe Szankasi, Todd W KelleyAnnals of Hematology|November 12, 2015
Detection of BCR-ABL1 mutations that confer tyrosine kinase inhibitor resistance using massively parallel, next generation sequencingPhilippe Szankasi, Jonathan A Schumacher, Todd W KelleyDiagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B|February 17, 2005
Molecular diagnostic techniques for the clinical evaluation of gliomasTodd W Kelley, Raymond R Tubbs, Richard A PraysonApplied Immunohistochemistry & Molecular Morphology : AIMM|November 13, 2004
Estrogen and progesterone receptor expression in uterine and extrauterine leiomyosarcomas: an immunohistochemical studyTodd W Kelley, Ernest C Borden, John R GoldblumAmerican Journal of Clinical Pathology|November 21, 2007
The ratio of FOXP3+ regulatory T cells to granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expressionTodd W Kelley, Brad Pohlman, Paul Elson, et al.Leukemia Research|June 19, 2004
Treatment of human chronic lymphocytic leukemia cells with the proteasome inhibitor bortezomib promotes apoptosisTodd W Kelley, Serhan Alkan, Gordan Srkalovic, et al.Archives of Pathology & Laboratory Medicine|August 26, 2014
Molecular genetic biomarkers in myeloid malignanciesAnna P Matynia, Philippe Szankasi, Wei Shen, et al.Pageof 5